180P FIRE-6: Longitudinal immune profiling identified disturbed NK cell functionality in RAS/BRAF wild-type metastatic colorectal cancer patients and during combined treatment with FOLFIRI, cetuximab followed by avelumab maintenance

• DOI: 10.1016/j.annonc.2024.08.2185
• Publication Date: 2024-09-17T21:01:21Z
• Authors: P. Schiele; S. Kolling; S. Stintzing; C. Junkuhn; A. Walter; S. Rosnev; J. von Einem; W. Schöning; I. Sauer; D.P. Modest; K. Heinrich; L. Weiss; L. Bullinger; M. Frentsch; V. Heinemann; I-K. Na